Objective informational resource
for industry professionals

Вас может заинтересовать:

Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
WEB only
Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
When can single-arm trials support drug filings?
WEB only
When can single-arm trials support drug filings?
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
X

error

Подобається наш журнал! Розкажи про нас

RSS
Follow by Email
Facebook
Twitter
LinkedIn
LinkedIn
Share
Для копіювання будь-ласка увійдіть в свій аккаунт